West Pharmaceutical Services, I

Historical 13F Holders

Symbol
WST
CUSIP
955306105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 955306105 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
8.5% 11/5/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 8.4% 4/24/2025
Event 3/31/2025
Vanguard Capital Management LLC 13G 7.5% 4/30/2026
Event 3/31/2026
Vanguard Portfolio Management LLC 13G 5.7% 4/29/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 516 19.9 M $7.35B
2026 Q2 840 70.5 M $25.2B
2026 Q1 762 71.1 M $17.8B
2025 Q4 809 70.4 M $19.3B
2025 Q3 764 68.8 M $18.0B
2025 Q2 737 70.0 M $15.3B
2025 Q1 725 69.9 M $15.6B
2024 Q4 753 69.8 M $22.9B
2024 Q3 740 68.6 M $20.5B
2024 Q2 784 68.3 M $22.4B
2024 Q1 785 68.5 M $27.0B
2023 Q4 788 68.7 M $24.1B
2023 Q3 762 68.6 M $25.8B
2023 Q2 736 68.1 M $25.9B
2023 Q1 702 69.6 M $24.0B
2022 Q4 643 69.1 M $16.3B
2022 Q3 642 68.6 M $16.9B
2022 Q2 660 68.8 M $20.8B
2022 Q1 724 70.6 M $28.2B
2021 Q4 734 69.5 M $32.2B
2021 Q3 676 67.4 M $28.5B
2021 Q2 647 69.3 M $24.7B
2021 Q1 596 68.7 M $19.3B
2020 Q4 598 68.8 M $19.7B
2020 Q3 580 68.4 M $18.8B
2020 Q2 528 69.2 M $15.8B
2020 Q1 473 67.4 M $10.3B
2019 Q4 447 67.9 M $10.2B
2019 Q3 411 67.5 M $9.57B
2019 Q2 376 67.9 M $8.52B
2019 Q1 380 68.1 M $7.50B
2018 Q4 358 69.7 M $6.83B
2018 Q3 357 69.3 M $8.53B
2018 Q2 327 69.4 M $6.87B
2018 Q1 323 70.2 M $6.20B
2017 Q4 339 69.8 M $6.89B
2017 Q3 304 69.8 M $6.72B
2017 Q2 310 67.3 M $6.36B
2017 Q1 296 66.7 M $5.45B
2016 Q4 288 67.1 M $5.69B
2016 Q3 281 66.2 M $4.93B
2016 Q2 289 66.7 M $5.07B
2016 Q1 252 68.4 M $4.75B
2015 Q4 250 67.8 M $4.08B
2015 Q3 249 67.6 M $3.66B
2015 Q2 219 67.5 M $3.92B
2015 Q1 214 67.4 M $4.05B
2014 Q4 225 65.8 M $3.50B
2014 Q3 213 66.2 M $2.96B
2014 Q2 221 64.5 M $2.72B
2014 Q1 224 63.6 M $2.80B